Charles Riv Lab Rg
CRL
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
05/08/2025 - 22:15:00
Bid
- - -
Bid
Volume
Ask
- - -
Ask
Volume
141.36
+4.39 ( +3.21% )
-
-
-
-
More information
Analysis by TheScreener
06.05.2025
Evaluation Slightly negative  
Interest Very weak  
Sensibility High  
Analysis date: 06.05.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 07.02.2025.
Interest
  Very weak
One star since 29.04.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 22.04.2025 at a price of 106.89.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Negative
 
The forty day technical trend is negative since 25.03.2025.
4wk Rel Perf
  -24.68%
 
The four-week dividend-adjusted underperformance versus SP500 is 24.68%.
Sensibility
  High
The stock has been on the high-sensitivity level since 07.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.28%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.74%.
Mkt Cap in $bn
  5.87
With a market capitalization between $2 & $8bn, CHARLES RIVER LAB is considered a mid-cap stock.
G/PE Ratio
  0.73
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  10.47
The estimated PE is for the year 2027.
LT Growth
  7.63%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  18
For 1% of index variation, the stock varies on average by 0.18%.
Correlation
  0.08
Stock movements are totally independent of index variations.
Value at Risk
  27.71
The value at risk is estimated at USD 27.71. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  31.03.2004